Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Bilirubin Adsorption Therapy and Subsequent Liver Transplantation Cured Severe Bilirubin Encephalopathy in a Long-term Survival Patient with Crigler-Najjar Disease Type I
Kazuma KANEKOYo-ichi TAKEITsugutoshi AOKIShu-ichi IKEDAHidetoshi MATSUNAMISteven LYNCH
Author information
JOURNAL FREE ACCESS

2000 Volume 39 Issue 11 Pages 961-965

Details
Abstract

Crigler-Najjar disease (CN) type I is characterized by persistent unconjugated hyperbilirubinemia from birth. The male patient here was diagnosed with this disease as a neonate and had been treated by phototherapy. At age 16 he suddenly developed generalized convulsions, followed by impaired cognitive function. The serum level of bilirubin was extremely high (total bilirubin: 41.7 mg/dl) and there were no other detectable causes responsible for the metabolic encephalopathy. He received bilirubin adsorption therapy several times, and the bilirubin encephalopathy improved in response to the fall in the serum level of bilirubin. After this he underwent a successful liver transplantation in Australia, and recovery of his mental faculties was satisfactory. Within the subsequent 3 years epileptic abnormal discharges on the electroencephalogram disappeared. Phototherapy alone can not prevent the rise in the serum level of bilirubin in adolescent or adult patients with CN type I, therefore such patients tend to experience life-threatening bilirubin encephalopathy. To save patients with the acute onset type of bilirubin encephalopathy, sufficient bilirubin adsorption followed by liver transplantation appears to be the most recommended therapeutic approach.
(Internal Medicine 39: 961-965, 2000)

Content from these authors
© The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top